Small Animal Imaging (In-Vivo) Global Market Report 2026
상품코드:1948213
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소동물 이미징(In-Vivo) 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 31억 5,000만 달러에서 2026년에는 35억 4,000만 달러로, CAGR 12.4%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 전임상 연구 활동의 확대, 신약 개발 투자 증가, 학술 연구 자금의 확대, 질병 연구에서의 동물 모델 사용 증가, 첨단 이미징 기법의 보급 등이 주요 요인으로 작용한 것으로 보입니다.
소동물 이미징(In-Vivo) 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 55억 3,000만 달러에 달하고, CAGR은 11.8%를 기록할 전망입니다. 예측 기간 동안의 성장은 정밀의료 연구 도구에 대한 수요 증가, 중개연구에 대한 투자 확대, 종양학 및 신경학 연구 확대, AI 지원 진단의 보급 확대, 실시간 생물학적 이미징에 대한 집중도 강화에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 멀티모달 이미징 시스템 도입 증가, 비침습적 생체 영상 기술 활용 확대, AI 기반 영상 분석의 통합적 발전, 종단적 질병 모니터링 연구 확대, 고해상도 이미징 역량에 대한 집중 강화 등을 들 수 있습니다.
향후 몇 년 동안 의료 분야의 지출 증가는 소동물 이미징(In-Vivo) 시장의 성장을 뒷받침할 것으로 예상됩니다. 의료비란 공공지출과 민간지출을 포함한 의료서비스에 대한 총지출을 국내총생산(GDP) 대비 비율로 나타낸 것입니다. 의료비 지출의 증가와 건강관리에 대한 인식이 높아지면서 자가 관리 및 첨단 진단 기법의 채택을 촉진하고 있으며, 양전자방사선단층촬영(PET) 시스템이 소동물 이미징과 같은 기법에 적용되고 있습니다. 생체소동물 이미징은 비침습적이고 실시간으로 생물학적 과정의 가시화를 가능하게 하고, 신약개발 과정의 가속화, 질병 이해의 심화, 보다 효과적인 치료법 개발 지원을 통해 의료 생태계에 기여합니다. 예를 들어, 2024년 5월 영국 통계청(Office for National Statistics)이 발표한 보고서에 따르면, 2023년 영국의 의료비 지출은 명목 기준으로 5.6% 증가했고, 2022년 장기 의료 및 사회복지 지출은 실질 기준으로 2.8% 증가했습니다. 이러한 결과로 의료비 증가가 소동물 영상(In-Vivo) 시장 성장에 기여하고 있습니다.
소동물 이미징(In-Vivo) 분야의 주요 기업들은 종양학, 신경과학 등의 분야에서 고정밀, 정량적, 고처리량 전임상 연구에 대한 수요 증가에 대응하기 위해 실시간 동역학 분석 기능을 포함한 고급 이미징 소프트웨어 솔루션의 중요성을 강조하고 있습니다. 점점 더 강조되고 있습니다. 이러한 소프트웨어 솔루션은 기존의 정적 단일 시점 이미징을 넘어 시간 경과에 따른 동적 생물 발광 신호의 연속적인 획득 및 자동 평가를 통해 보다 종합적인 동적 프로파일 생성, 재현성 향상, 피크 신호 단계의 검출 정확도 향상을 실현합니다. 예를 들어, 2024년 4월, 미국에 본사를 둔 전임상 이미징 기술 제공 업체인 Spectral Instruments Imaging은 생체 내 이미징 소프트웨어의 최신 버전인 Aura 4.5를 발표했습니다. Aura 4.5는 '키네틱스 모드'를 탑재하여 생물 발광 신호의 전체 시간 경과(상승상, 정상상, 감쇠상 포함)를 자동으로 실시간으로 포착합니다. 이 플랫폼은 신호 강도 피크를 자동으로 판단하고 보고하기 때문에 연구자는 더 높은 감도와 생물학적 정확도를 달성할 수 있습니다. 또한, 이번 업데이트를 통해 데이터 수집이 간소화되어 수동 조작을 최소화할 수 있습니다. 이를 통해 약동학 분석, 유전자 발현 연구, 감염 모델 등 시간적, 시간적 제약이 있는 연구에서의 운영 효율을 높일 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Small animal imaging (in vivo) pertains to advanced imaging techniques designed for monitoring cellular activity, pharmacological effects, and disease progression in live animals. It enables the observation, definition, and quantification of normal and pathologic processes in living animal organs and tissues in a non-invasive manner.
Key components of small animal imaging (in vivo) include micro-MRI, optical imaging, nuclear imaging, and other elements. Micro-MRI, a non-invasive technique, produces detailed three-dimensional (3D) images of tissues without exposing the subject to harmful radiation. This approach finds various applications, such as monitoring treatment response, assessing biodistribution, determining drug/target engagement, detecting cancer cells, exploring biomarkers, conducting longitudinal studies, and investigating epigenetics. These applications are employed in veterinary clinics, veterinary hospitals, as well as veterinary institutes and research centers.
Tariffs are influencing the small animal imaging (in-vivo) market by increasing costs of imported imaging detectors, scanners, contrast agents, electronic components, and precision optics. Research institutions and pharmaceutical laboratories in North America and Europe are most affected due to reliance on advanced imported imaging systems, while Asia-Pacific faces cost pressures on system procurement. These tariffs are increasing capital investment requirements and delaying equipment upgrades. At the same time, they are supporting regional manufacturing partnerships, localized system assembly, and domestic innovation in preclinical imaging technologies.
The small animal imaging (in-vivo) market research report is one of a series of new reports from The Business Research Company that provides small animal imaging (in-vivo) market statistics, including small animal imaging (in-vivo) industry global market size, regional shares, competitors with a small animal imaging (in-vivo) market share, detailed small animal imaging (in-vivo) market segments, market trends and opportunities, and any further data you may need to thrive in the small animal imaging (in-vivo) industry. This small animal imaging (in-vivo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $3.15 billion in 2025 to $3.54 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to growth in preclinical research activities, increasing drug discovery investments, expansion of academic research funding, rising use of animal models in disease studies, availability of advanced imaging modalities.
The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $5.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine research tools, rising investments in translational research, expansion of oncology and neurological studies, growing adoption of ai-assisted diagnostics, increasing focus on real-time biological imaging. Major trends in the forecast period include increasing adoption of multimodal imaging systems, rising use of non-invasive in vivo imaging techniques, growing integration of ai-based image analysis, expansion of longitudinal disease monitoring studies, enhanced focus on high-resolution imaging capabilities.
Increasing healthcare sector spending is anticipated to support the expansion of the small animal imaging (in vivo) market in the coming years. Healthcare expenditure represents the total spending on health services, including both public and private outlays, expressed as a share of gross domestic product. Higher healthcare spending, along with growing awareness of health management, is promoting the adoption of self-care and advanced diagnostic approaches, where positron emission tomography systems are applied in methods such as small animal imaging. In vivo small animal imaging benefits the healthcare ecosystem by enabling noninvasive, real-time visualization of biological processes, accelerating drug discovery timelines, enhancing disease understanding, and supporting the development of more effective therapeutic solutions. For example, in May 2024, a report released by the Office for National Statistics, a United Kingdom-based government statistical authority, indicated that healthcare expenditure in the United Kingdom rose by 5.6% in nominal terms in 2023, while long-term health and social care spending increased by 2.8% in real terms in 2022. As a result, rising healthcare expenditure is contributing to the growth of the small animal imaging (in vivo) market.
Leading companies operating in the small animal imaging (in vivo) space are increasingly emphasizing advanced imaging software solutions, including real-time kinetic analysis capabilities, to address the growing demand for highly accurate, quantitative, and high-throughput preclinical research in areas such as oncology and neuroscience. These software solutions enable continuous acquisition and automated evaluation of dynamic bioluminescent signals over time, moving beyond conventional static single-timepoint imaging and generating more comprehensive kinetic profiles, improved reproducibility, and enhanced detection of peak signal phases. For instance, in April 2024, Spectral Instruments Imaging, a United States-based provider of preclinical imaging technologies, introduced Aura 4.5, the newest release of its in vivo imaging software. Aura 4.5 features a Kinetics mode that supports automated, real-time capture of bioluminescent signals across their entire temporal progression, including rise, plateau, and decay phases. The platform automatically determines and reports peak signal intensity, enabling researchers to achieve greater sensitivity and biological precision. In addition, the update simplifies data collection and minimizes manual handling, improving operational efficiency for longitudinal and time-critical studies such as pharmacokinetic analyses, gene expression research, and infection models.
In February 2024, Bruker Corporation, a US-based biotechnology research company, acquired Spectral Instruments Imaging for an undisclosed sum. This acquisition is intended to bolster Bruker Corporation's imaging technology capabilities, particularly in advanced imaging systems for life sciences and materials research. The integration of Spectral Instruments Imaging's expertise in specialized imaging solutions will enhance Bruker's offerings in this area. Spectral Instruments Imaging is a US-based company known for its advanced imaging solutions.
Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation
North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the small animal imaging (in-vivo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The small animal imaging (in-vivo) market includes revenues earned by PET, X-ray CT, MRI, and SPECT scanners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Small Animal Imaging (In-Vivo) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses small animal imaging (in-vivo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for small animal imaging (in-vivo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small animal imaging (in-vivo) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Component: Micro-MRI; Optical Imaging; Nuclear Imaging; Other Components
2) By Application: Monitoring Treatment Response; Bio Distribution, Determining Drug or Target Engagement; Cancer Cell Detection; Biomarkers; Longitudinal Studies; Epigenetics
3) By End User: Veterinary Clinics; Veterinary Hospitals; Veterinary Institutes and Research Centers
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Industry 4.0 & Intelligent Manufacturing
4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
4.2. Major Trends
4.2.1 Increasing Adoption Of Multimodal Imaging Systems
4.2.2 Rising Use Of Non-Invasive In Vivo Imaging Techniques
4.2.3 Growing Integration Of Ai-Based Image Analysis
4.2.4 Expansion Of Longitudinal Disease Monitoring Studies
4.2.5 Enhanced Focus On High-Resolution Imaging Capabilities
5. Small Animal Imaging (In-Vivo) Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Academic Research Institutes
5.4 Contract Research Organizations
5.5 Veterinary Research Centers
6. Small Animal Imaging (In-Vivo) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Small Animal Imaging (In-Vivo) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Small Animal Imaging (In-Vivo) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Small Animal Imaging (In-Vivo) Market Size, Comparisons And Growth Rate Analysis
7.3. Global Small Animal Imaging (In-Vivo) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Small Animal Imaging (In-Vivo) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Small Animal Imaging (In-Vivo) Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Small Animal Imaging (In-Vivo) Market Segmentation
9.1. Global Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
9.2. Global Small Animal Imaging (In-Vivo) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
9.3. Global Small Animal Imaging (In-Vivo) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
9.4. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Micro-MRI, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Optical Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
9.6. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Nuclear Imaging, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Small Animal Imaging (In-Vivo) Market, Sub-Segmentation Of Other Components, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems
10. Small Animal Imaging (In-Vivo) Market Regional And Country Analysis
10.1. Global Small Animal Imaging (In-Vivo) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Small Animal Imaging (In-Vivo) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Small Animal Imaging (In-Vivo) Market
11.1. Asia-Pacific Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Small Animal Imaging (In-Vivo) Market
12.1. China Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Small Animal Imaging (In-Vivo) Market
13.1. India Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Small Animal Imaging (In-Vivo) Market
14.1. Japan Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Small Animal Imaging (In-Vivo) Market
15.1. Australia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Small Animal Imaging (In-Vivo) Market
16.1. Indonesia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Small Animal Imaging (In-Vivo) Market
17.1. South Korea Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Small Animal Imaging (In-Vivo) Market
18.1. Taiwan Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Small Animal Imaging (In-Vivo) Market
19.1. South East Asia Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Small Animal Imaging (In-Vivo) Market
20.1. Western Europe Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Small Animal Imaging (In-Vivo) Market
21.1. UK Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Small Animal Imaging (In-Vivo) Market
22.1. Germany Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Small Animal Imaging (In-Vivo) Market
23.1. France Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Small Animal Imaging (In-Vivo) Market
24.1. Italy Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Small Animal Imaging (In-Vivo) Market
25.1. Spain Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Small Animal Imaging (In-Vivo) Market
26.1. Eastern Europe Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Small Animal Imaging (In-Vivo) Market
27.1. Russia Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Small Animal Imaging (In-Vivo) Market
28.1. North America Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Small Animal Imaging (In-Vivo) Market
29.1. USA Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Small Animal Imaging (In-Vivo) Market
30.1. Canada Small Animal Imaging (In-Vivo) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Small Animal Imaging (In-Vivo) Market
31.1. South America Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Small Animal Imaging (In-Vivo) Market
32.1. Brazil Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Small Animal Imaging (In-Vivo) Market
33.1. Middle East Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Small Animal Imaging (In-Vivo) Market
34.1. Africa Small Animal Imaging (In-Vivo) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Small Animal Imaging (In-Vivo) Market, Segmentation By Component, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Small Animal Imaging (In-Vivo) Market Regulatory and Investment Landscape
36. Small Animal Imaging (In-Vivo) Market Competitive Landscape And Company Profiles
36.1. Small Animal Imaging (In-Vivo) Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Small Animal Imaging (In-Vivo) Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Small Animal Imaging (In-Vivo) Market Company Profiles
36.3.1. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.2. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Mediso Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Aspect Imaging Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Spectral Instruments Imaging LLC Overview, Products and Services, Strategy and Financial Analysis
37. Small Animal Imaging (In-Vivo) Market Other Major And Innovative Companies
